Hull Hans
SEC CIK 1614876 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PLRX | PLIANT THERAPEUTICS, INC. | Chief Business Off | 251.7K | — | $1.82M | 15 | 2022-12-19 | 2025-01-23 |
Most active insiders at PLRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Coulie Bernard | Pres, CEO, Dir | — | $114.4K |
| 2 | Cummings Keith Lamont | CFO | — | $30.7K |
| 3 | Cheung Lily | Chief Human Resource Off | — | $9,644 |
| 4 | Kuo Minnie | COO | — | $8,854 |
Hull Hans made no open-market trades at PLRX in the last 12 months.
Transactions 15
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-01-27 | 2025-01-23 | PLRX | PLIANT THERAPEUTICS, INC. | Hull Hans | Chief Business Off | A - Grant | $0.00 | +40.1K | 251.7K | +19% | $0 |
| 2025-01-22 | 2025-01-17 | PLRX | PLIANT THERAPEUTICS, INC. | Hull Hans | Chief Business Off | S - Sale | $11.20 | -15.9K | 211.6K | -7% | -$178.5K | |
| 2024-07-12 | 2024-07-10 | PLRX | PLIANT THERAPEUTICS, INC. | Hull Hans | Chief Business Off | S - Sale | $11.56 | -9,900 | 227.5K | -4% | -$114.4K | |
| 2024-07-11 | 2024-07-09 | PLRX | PLIANT THERAPEUTICS, INC. | Hull Hans | Chief Business Off | A - Grant | $0.00 | +19.3K | 237.4K | +9% | $0 | |
| D | 2024-01-24 | 2024-01-23 | PLRX | PLIANT THERAPEUTICS, INC. | Hull Hans | Chief Business Off | A - Grant | $0.00 | +31.5K | 216.6K | +17% | $0 |
| 2024-01-19 | 2024-01-17 | PLRX | PLIANT THERAPEUTICS, INC. | Hull Hans | Chief Business Off | S - Sale | $17.23 | -9,786 | 185.1K | -5% | -$168.6K | |
| DM | 2023-08-07 | 2023-08-03+ | PLRX | PLIANT THERAPEUTICS, INC. | Hull Hans | Chief Business Off | S - Sale+OE | $20.01 | -31.3K | 206.1K | -13% | -$626.6K |
| DM | 2023-08-07 | 2023-08-03+ | PLRX | PLIANT THERAPEUTICS, INC. | Hull Hans | Chief Business Off | M - OptEx | $2.08 | +10.6K | 207.9K | +5% | +$22.0K |
| 2023-07-19 | 2023-07-17 | PLRX | PLIANT THERAPEUTICS, INC. | Hull Hans | Chief Business Off | S - Sale | $18.01 | -17.9K | 219.2K | -8% | -$323.0K | |
| 2023-07-18 | 2023-07-14 | PLRX | PLIANT THERAPEUTICS, INC. | Hull Hans | Chief Business Off | A - Grant | $0.00 | +35.2K | 237.1K | +17% | $0 | |
| 2023-04-03 | 2023-03-30 | PLRX | PLIANT THERAPEUTICS, INC. | Hull Hans | Chief Business Off | S - Sale | $26.52 | -9,036 | 202.0K | -4% | -$239.6K | |
| 2023-03-31 | 2023-03-29 | PLRX | PLIANT THERAPEUTICS, INC. | Hull Hans | Chief Business Off | A - Grant | $0.00 | +17.6K | 211.0K | +9% | $0 | |
| D | 2023-01-27 | 2023-01-25 | PLRX | PLIANT THERAPEUTICS, INC. | Hull Hans | Chief Business Off | A - Grant | $0.00 | +54.0K | 192.2K | +39% | $0 |
| 2022-12-21 | 2022-12-19 | PLRX | PLIANT THERAPEUTICS, INC. | Hull Hans | Chief Business Off | A - Grant | $0.00 | +17.6K | 146.9K | +14% | $0 | |
| 2022-12-21 | 2022-12-20 | PLRX | PLIANT THERAPEUTICS, INC. | Hull Hans | Chief Business Off | S - Sale | $19.10 | -8,748 | 138.2K | -6% | -$167.1K |
Purchase Sale Sale after option exercise All abbreviations